Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by jakethesnake2on May 23, 2018 11:03pm
405 Views
Post# 28073216

RE:RE:RE:Insider buying

RE:RE:RE:Insider buying
Bayman,
Fred confirmed that Blackout is still in effect for senior exec's and board members.

The main reason for the blackout at the moment is the ongoing negotiation for a PBI-4050 deal. Since that was announced at the AGM that we were in advanced negotiations, it is in the public domain. However Senior EXEC and Board Members know more than the typical employee, hence the continuing blackout period for them.
 
Frederic Dumais
Directeur principal, Communications et relations avec les investisseurs, Senior Director, Communications and Investor Relations
440 Boul. Armand-Frappier
Laval, Quebec H7V 4B4
+1 450 781 0115
f.dumais@prometic.com
Avis : Ce courriel est confidentiel et est l'usage exclusif du destinataire. Si vous n’tes pas le ou la destinataire vis(e), veuillez nous en informer immdiatement par courriel,  effacer l'original sans en conserver de copie et ne pas en dvoiler le contenu ni utiliser l’information pour quelque fin que ce soit.
Notice : This e-mail is confidential and intended for the exclusive use of the addressee. If you are not the intended addressee, please notify us immediately by e-mail, delete the original without keeping a copy and do not disclose its content or use the information for any purposes.
 
 
Bullboard Posts